文献速递先天性心脏病外科心外重症与机械循环支持

Berlin Heart EXCOR 儿童心室辅助临床结局系统综述

Clinical outcomes of paediatric patients supported by the Berlin Heart EXCOR: a systematic review.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

该系统综述于2018年4月检索文献,纳入报告至少15名儿童使用 Berlin Heart EXCOR 心室辅助装置临床结局的研究,共纳入18篇文献。结果显示死亡率范围6.3%(CI 0.0-18.1%)至38.9%(2.8-75.0%),移植率37.0%(CI 18.8-55.2%)至72.5%(CI 63.9-81.2%),成功撤机率0.0%至20.7%(CI 6.0-35.5%)。

要点

  • 儿童 BH EXCOR 支持者死亡率6.3%至38.9%,移植率37.0%至72.5%
  • 1岁以下儿童死亡率20.0%至55.5%,移植率0.0%至62.5%
  • BiVAD 支持临床结局似差于 LVAD,卒中发生率5.0%至47.0%

核心结论

  • 尽管卒中和泵血栓等不良事件发生率高,终末期心衰等待心脏移植的儿童仍应考虑心室辅助支持。
  • BiVAD 支持的临床结局似乎差于 LVAD 支持。
  • 需进一步研究器械植入最佳时机与抗凝方案。

研究设计与样本

  • 2018年4月进行系统文献检索。
  • 纳入报告至少15名儿童接受 BH EXCOR 心室辅助装置临床结局的研究,共18篇文献。

主要发现

  • 死亡率范围为6.3%(CI 0.0-18.1%)至38.9%(2.8-75.0%)。
  • 移植率范围为37.0%(CI 18.8-55.2%)至72.5%(CI 63.9-81.2%)。
  • 成功撤机率为0.0%至20.7%(CI 6.0-35.5%)。
  • 1岁以下儿童死亡率20.0%至55.5%,移植率0.0%至62.5%。
  • 全部 BH EXCOR 支持儿童卒中发生率为5.0%至47.0%。

临床怎么用

  • 终末期心衰等待心脏移植的儿童可考虑 BH EXCOR 心室辅助支持。
  • 需关注卒中与泵血栓等不良事件,BiVAD 支持者结局似更差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ventricular assist devices (VADs) are widely accepted as therapy to bridge children to heart transplantation. We provide a systematic review of the current state of clinical outcomes in children after paediatric VAD support by the Berlin Heart EXCOR (BH EXCOR) device. A systematic literature search was performed in April 2018. Studies reporting clinical outcomes in at least 15 children supported by a BH EXCOR VAD were included. Additionally, we focused on outcomes in small children and compared outcomes of children supported by a left ventricular assist device (LVAD) versus children supported by a biventricular assist device (BiVAD). Eighteen publications fulfilled the inclusion criteria and were included in this systematic review. Mortality rates ranged from 6.3% [confidence interval (CI) 0.0-18.1%] to 38.9% (2.8-75.0%) while transplantation rates ranged from 37.0% (CI 18.8-55.2%) to 72.5% (CI 63.9-81.2%) and successful weaning rates from 0.0% to 20.7% (CI 6.0-35.5%). In children under 1 year of age, mortality rates ranged from 20.0% to 55.5% and transplantation rates ranged from 0.0% to 62.5%. BiVAD support seemed to result in worse clinical outcomes than LVAD support. Incidence of stroke ranged from 5.0% to 47.0% in all children supported with the BH EXCOR. Although a high incidence of adverse events such as stroke and pump thrombosis is reported, VAD support should be considered in children with end-stage heart failure awaiting heart transplantation. Further research is warranted, especially on optimal timing of device implantation and anticoagulation regimens.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Rohde S, Antonides CFJ, Dalinghaus M, et al. Clinical outcomes of paediatric patients supported by the Berlin Heart EXCOR: a systematic review. Eur J Cardiothorac Surg. 2019. PMID: 30932146. doi:10.1093/ejcts/ezz092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。